(Q43664061)

English

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial

scientific article published in June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hydrochlorothiazide

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J B McGill

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

P A Reilly

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

833-850

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertension awareness, treatment and control in the community: is the 'rule of halves' still valid?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative safety and tolerability of angiotensin II receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypokalaemia and diuretics: an analysis of publications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose hydrochlorothiazide (12.5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension. Assessment by ambulatory blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing for the existence of a desirable dose combination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Testing whether an identified treatment is best

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronotherapeutics for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980072-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(01)80072-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43664061&oldid=2164956361"